BDBM50216437 CHEMBL397595::N-(4-(3-(trifluoromethyl)benzamido)benzyl)-N,N-dimethyl-tetrahydro-2H-pyran-4-aminium
SMILES: C[N+](C)(Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1)C1CCOCC1
InChI Key: InChIKey=HLTFREXRHSGZIS-UHFFFAOYSA-O
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-C chemokine receptor type 2 (Homo sapiens (Human)) | BDBM50216437 (CHEMBL397595 | N-(4-(3-(trifluoromethyl)benzamido)...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 2.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL | Assay Description Displacement of [125I]MCP1 from CCR2 receptor expressed in THP1 cells | Bioorg Med Chem Lett 17: 4382-6 (2007) Article DOI: 10.1016/j.bmcl.2007.01.115 BindingDB Entry DOI: 10.7270/Q2F47NVR | |||||||||||
More data for this Ligand-Target Pair |